Published by Iain Gilbert on 23rd September 2026
(Sharecast News) - Drugmaker Astrazeneca said on Wednesday that its Trixeo Aerosphere candidate has been approved in the European Union as a maintenance treatment for asthma in patients aged 12 and over.
URL: http://www.digitallook.com/dl/news/story/36230297/...